Considering increased expression of IL-17 has been observed in the intestinal mucosa of patients with IBD, IL-17 may facilitate the progression of IBD, which is mainly related to intestinal mucosal immune response, for using neutralizing antibody, IBD symptoms were effectively relieved. Here, IL17A is linked to irritable bowel syndrome.